Rheumatoid arthritis (RA) can have a major effect on health-related quality of life and can lead to reduction in physical function and in mental health ([@CIT0006], [@CIT0016], [@CIT0003]). Orthopedic surgery has improved the function and quality of life of patients with RA. A decreasing rate of RA-related orthopedic surgery in the Nordic countries has been reported ([@CIT0008], [@CIT0029], [@CIT0014], [@CIT0011], [@CIT0024]) and has been explained by the development of more effective pharmacological regimes ([@CIT0005], [@CIT0014], [@CIT0027], [@CIT0030], [@CIT0026]). However, if medical treatment fails, surgical intervention is needed. Patient-related outcome measures are frequently used to quantify the effectiveness of treatment and the long-term effect of RA on the patient\'s functioning and well-being ([@CIT0015], [@CIT0017], [@CIT0027]). Some recent studies have evaluated the effect of orthopedic interventions in other patient groups ([@CIT0021], [@CIT0013]). Few studies have assessed patient-relevant outcomes after orthopedic surgery in patients with RA.

The Swedish National Register of Rheuma Surgery (RAKIR) was established in 2007 and has been used at Spenshult Hospital for Rheumatic Diseases. The main aim of RAKIR is to measure how surgical procedures affect pain, function, activity, and quality of life in RA patients, in order to improve the results. Data on patient-reported pain, function, and health-related quality of life of patients undergoing surgery have been registered since September 2007, together with data on complications and revision surgery. The objective of this study was to examine the effect of RA-related surgical interventions in the lower extremities, as measured by the patient-administered questionnaires HAQ and SF-36. This analysis is based on the first data from RAKIR.

Methods {#ss2}
=======

Patients {#ss3}
--------

Between September 2007 and June 2009, 516 operations in the lower extremities were performed in 439 patients at Spenshult Hospital for Rheumatic Diseases ([Figure 1](#F1){ref-type="fig"}). Patients undergoing surgery were asked to complete the patient-administered questionnaires SF-36 and HAQ preoperatively at the ward. The same questionnaires were sent to the patients by mail 6 months and 12 months postoperatively without any reminders. The procedures were all RA-related joint surgery ([Table 1](#T1){ref-type="table"}). Operation codes were divided into 4 groups according to the anatomical region: hip, knee, foot, and ankle. Preoperative data were available for 261 patients. 28 patients underwent surgery twice or more, and completed the preoperative questionnaires at least once during the study period, but only data referring to the first intervention were analyzed. 3 patients were excluded either due to surgery of the upper extremity in the same session (n = 1) or due to operations unrelated to RA (n = 2). Data for the remaining 258 patients (212 women) were analyzed: 26 hip patients, 39 knee patients, 162 foot patients, and 31 ankle patients. Mean age at surgery was 64 (20--86) years. 98 patients had had one or more previous intervention performed, including hand/wrist (n = 49), elbow (n = 16), shoulder (n = 7), back or neck (n = 9), hip (n = 21), knee (n = 30), and foot (n = 60) patients. The individual change in SF-36 and HAQ scores was calculated as the difference between scores preoperatively and at 12 months postoperatively. Peroperative complications were reported in 7 patients (hip, n = 2; foot, n = 2; ankle, n = 2; knee, n = 1). Postoperative complications were reported in 3 patients.

![Flow chart of patients.](ORT-1745-3674-083-179_g001){#F1}

###### 

Orthopedic interventions

  Intervention           n (%)
  ---------------------- ---------
  Forefoot arthrodesis   77 (29)
  Stainsby               31 (11)
  Hindfoot arthrodesis   37 (13)
  Ankle arthroplasty     13 (5)
  Ankle arthrodesis      17 (6)
  THR                    26 (9)
  TKR                    34 (12)
  Forefoot osteotomy     18 (7)
  Phalang resection      9 (3)
  Hindfoot osteotomy     2 (1)
  Knee arthroscopy       2 (1)
  Others                 9 (3)

Questionnaires {#ss4}
--------------

The Medical Outcome Study Short Form-36 (SF-36) (Ware and Sherbourne 1992) includes one multi-item scale that assesses 8 dimensions of health: physical functioning (PF), social functioning (SF), role limitations because of physical health problems (RP), bodily pain (BP), general mental health (psychological distress and well-being; MH), limitations in usual role activities because of emotional problems (RE), vitality (energy and fatigue; VT), and general health perceptions (GH). Each subscale is scored from 0 to 100, with 0 indicating extreme problems and 100 indicating no problems. The SF-36 is a widely used generic measure of health status and has been validated for Swedish conditions ([@CIT0025]).

The Stanford Health Assessment Questionnaire (HAQ) disability index ([@CIT0010]) is a disease-specific questionnaire containing 20 items and assesses the degree of difficulty in performing activities of daily living during the previous week. The following response categories are available for each question: without any difficulty (score 0), with some difficulty (score 1), with much difficulty (score 2), or unable to do (score 3). The activities are grouped into 8 dimensions: dressing and grooming, rising, eating, walking, hygiene, reach, grip, and other activities. The HAQ is widely used internationally in patients with RA---in clinical practice as well as in research. It has been translated and validated for Swedish conditions ([@CIT0007]).

Statistics {#ss5}
----------

For comparison of preoperative and follow-up questionnaire data, Friedman\'s test (comparing baseline data, 6-month data, and 12-month data) and Wilcoxon\'s signed rank test (comparing pairwise data between 2 different examinations, e.g., baseline data and 12-month data) were used. To quantify mean changes in measured outcomes during follow-up, the paired t-test was used for computation of 95% confidence intervals (CIs). For comparisons between groups, the Mann-Whitney test was used. Continuous outcomes are given as mean (SD) since this is customary in describing SF-36 data. Values of p \< 0.05 were considered significant.

Power analysis was performed before the start of the study. For a difference of 10 units in the SF-36 subscales and a difference of 0.3 units in the HAQ, with a power of 80% between preoperative and postoperative data (p \< 0.05), we calculated that 35 patients per group would be required.

We carried out sensitivity analysis to address the issue of missing data (loss to follow-up). The sensitivity of the reported statistical results for HAQ and SF-36 data was evaluated by imputing baseline data (for the non-responders). Pre- and postoperative data, including the imputed values, were then compared using Wilcoxon\'s signed rank test. Statistical analysis was performed with the SPSS software version 17.0.

Ethics {#ss6}
------

The ethics regional board of Lund approved the study (no. 521/2007).

Results {#ss7}
=======

At the 12-month follow-up, responses were available from 165 patients (141 women) with a mean age at surgery of 64 (27--84) years ([Table 2](#T2){ref-type="table"}). The distribution of surgery was as follows: foot (n = 102), ankle (n = 21), knee (n = 27), and hip (n = 15). 93 patients did not complete the 12-month follow-up questionnaires. There were no statistically significant differences between responders and non-responders regarding age, preoperative HAQ score, or preoperative SF-36 score. Friedman\'s test showed a difference in mean ranks for HAQ and for SF-36 subscales PF, RP, BP, and SF ([Table 3](#T3){ref-type="table"}). Patients reported statistically significant improvements in scores from before surgery to 12 months postoperatively in HAQ and in SF-36 subscales PF, RP, BP, SF, and RE. Statistically significant improvements were evident at 6 months (compared to preoperatively) in the same subscales, with the exception of RE. VT improved at 6 months but not at 12 months. When the subgroups were analyzed separately, foot patients reported significant improvement in SF-36 PF, RP, and BP scores at 6 and 12 months relative to preoperative levels ([Table 4](#T4){ref-type="table"}). Ankle patients had significant improvements in BP and SF compared to preoperatively ([Table 5](#T5){ref-type="table"}). Ankle patients who underwent total joint replacement (n = 10) had significant improvement in pain, and the improvement in PF was close to significant (p = 0.05) while ankle patients who underwent arthrodesis surgery (n = 11) only had significant improvement in SF. Knee patients ([Table 6](#T6){ref-type="table"}) had significant improvements in HAQ and in SF-36 PF, RP, BP, VT, SF, and RE at 12 months. Hip patients had significant improvements in HAQ and in SF-36 PF, BP, VT, SF, and RE at 12 months ([Table 7](#T7){ref-type="table"}).

###### 

Patient characteristics

                                                                         Responders   Foot         Ankle        Knee         Hip          Non-responders
  ---------------------------------------------------------------------- ------------ ------------ ------------ ------------ ------------ ----------------
  n                                                                      165          102          21           27           15           93
  Women, n (%)                                                           141 (86)     94 (92)      16 (76)      20 (74)      11 (73)      71 (76)
  Age in years **[^a^](#T2-N1){ref-type="fn"}**                          64 (11)      65 (11)      62 (13)      68 (9)       61 (14)      62 (13)
  Preoperative HAQ score **[^a^](#T2-N1){ref-type="fn"}**                1.1 (0.58)   1.0 (0.56)   1.4 (0.56)   1.2 (0.58)   1.3 (0.60)   1.1 (0.60)
  Preoperative SF-36 scores **[^a,\ b^](#T2-N1 T2-N2){ref-type="fn"}**                                                                    
   PF                                                                    39 (23)      44 (23)      28 (17)      35 (22)      28 (22)      41 (23)
   RP                                                                    29 (39)      34 (41)      19 (32)      27 (37)      15 (31)      29 (36)
   BP                                                                    37 (21)      40 (21)      34 (22)      36 (17)      25 (26)      36 (21)
   GH                                                                    52 (21)      51 (21)      51 (19)      51 (20)      59 (22)      52 (22)
   VT                                                                    47 (25)      51 (25)      38 (19)      48 (21)      33 (25)      45 (24)
   SF                                                                    69 (26)      73 (26)      56 (25)      69 (23)      60 (31)      68 (25)
   RE                                                                    58 (45)      64 (44)      51 (44)      42 (49)      60 (44)      62 (42)
   MH                                                                    73 (19)      76 (19)      63 (22)      71 (18)      79 (21)      74 (19)

**^a^** Values are mean (SD)

**^b^** See Methods for a full explanation of the 8 dimensions of the SF-36.

###### 

HAQ and SF-36 scores before and after surgery (n = 165)

                            Baseline     6 months      12 months    Mean change (SD; CI)             p-value (Friedman\'s test)   p-value
  ------------------------- ------------ ------------- ------------ -------------------------------- ---------------------------- ----------
  HAQ score, mean (SD)      1.1 (0.58)   0.99 (0.62)   1.0 (0.62)   --0.11 (0.44; --0.18 to 0.041)   \< 0.001                     0.006
  SF-36 scores, mean (SD)                                                                                                         
   PF                       39 (23)      49 (24)       50 (25)      11 (23; 7.3--14)                 \< 0.001                     \< 0.001
   RP                       29 (39)      44 (41)       41 (42)      12 (41; 5.8--19 )                0.001                        \< 0.001
   BP                       37 (21)      52 (24)       50 (24)      13 (24; 9.5--17)                 \< 0.001                     \< 0.001
   GH                       52 (21)      52 (23)       50 (21)      --2.2 (19; --5.0 to 0.70)        0.6                          0.2
   VT                       47 (25)      52 (24)       51 (23)      3.5 (21; 0.24--6.8)              0.1                          0.08
   SF                       69 (26)      77 (25)       75 (26)      6.4 (24; 2.7--10)                \< 0.001                     0.001
   RE                       58 (45)      67 (42)       67 (42)      9.4 (48; 1.7--17)                0.2                          0.01
   MH                       73 (19)      77 (20)       74 (20)      0.35 (19; --2.7 to 3.4)          0.2                          0.6

###### 

HAQ and SF-36 scores before and after surgery: foot (n = 102)

                            Baseline     6 months      12 months     Mean change (SD; CI)          p-value
  ------------------------- ------------ ------------- ------------- ----------------------------- ----------
  HAQ score, mean (SD)      1.0 (0.56)   0.97 (0.63)   0.96 (0.59)   --0.036 (0.41; -0.12-0.048)   0.8
  SF-36 scores, mean (SD)                                                                          
   PF                       44 (23)      50 (24)       51 (24)       7.4 (22; 3.1--12)             \< 0.001
   RP                       34 (41)      45 (40)       42 (40)       8.4 (40; 0.32--17)            0.03
   BP                       40 (21)      49 (23)       48 (22)       8.0 (20; 3.9--12)             \< 0.001
   GH                       51 (21)      50 (22)       49 (23)       --2.0 (20; --6.0 to 2.0)      0.4
   VT                       51 (25)      53 (24)       50 (24)       --1.0 (20; --4.9 to 2.9)      0.5
   SF                       73 (26)      76 (24)       75 (26)       1.7 (24; --3.0 to 6.5)        0.4
   RE                       64 (44)      66 (42)       67 (42)       3.0 (48; --6.7 to 13)         0.5
   MH                       76 (19)      77 (18)       72 (20)       --3.4 (20; --7.4 to 0.59)     0.1

###### 

HAQ and SF-36 scores before and after surgery: ankle (n = 21)

                            Baseline     6 months     12 months    Mean change (SD; CI)          p-value
  ------------------------- ------------ ------------ ------------ ----------------------------- ---------
  HAQ score, mean (SD)      1.4 (0.56)   1.2 (0.53)   1.4 (0.53)   0.00 (0.41; --0.19 to 0.19)   0.8
  SF-36 scores, mean (SD)                                                                        
   PF                       27 (17)      36 (19)      33 (22)      5.1 (21; --4.3 to 15)         0.2
   RP                       19 (32)      26 (39)      27 (41)      8.3 (41; --10 to 27)          0.4
   BP                       34 (22)      55 (25)      46 (23)      13 (24; 2.0--23)              0.03
   GH                       51 (19)      52 (20)      46 (20)      --4.0 (14; --11 to 2.8)       0.2
   VT                       38 (19)      43 (27)      46 (19)      8.1 (20; --1.3 to 17)         0.2
   SF                       56 (25)      72 (30)      69 (32)      13 (21; 3.7--23)              0.02
   RE                       51 (44)      59 (45)      55 (46)      5.0 (56; --21 to 31)          0.7
   MH                       63 (22)      70 (23)      71 (18)      7.8 (20; --1.8 to 17)         0.1

###### 

HAQ and SF-36 scores before and after surgery: knee (n = 27)

                            Baseline     6 months     12 months    Mean change (SD; CI)              p-value
  ------------------------- ------------ ------------ ------------ --------------------------------- ----------
  HAQ score, mean (SD)      1.2 (0.58)   1.0 (0.62)   1.0 (0.66)   --0.29 (0.29; --0.41 to --0.17)   \< 0.001
  SF-36 scores, mean (SD)                                                                            
   PF                       35 (22)      52 (21)      55 (22)      20 (19; 12--27)                   \< 0.001
   RP                       27 (37)      50 (45)      51 (46)      26 (47; 6.9--44)                  0.01
   BP                       36 (17)      53 (22)      58 (23)      21 (24; 12--31)                   \< 0.001
   GH                       51 (20)      49 (22)      50 (18)      --1.4 (16; --8.0 to 5.1)          0.8
   VT                       48 (21)      53 (22)      56 (21)      8.5 (18; 1.4--16)                 0.02
   SF                       69 (23)      83 (21)      82 (20)      13 (20; 5.7--21)                  0.003
   RE                       42 (49)      67 (44)      69 (41)      27 (46; 8.3--46)                  0.007
   MH                       71 (18)      73(20)       76 (20)      5.1 (14; --0.32 to 11)            0.06

###### 

HAQ and SF-36 scores before and after surgery: hip (n = 15)

                            Baseline     6 months      12 months     Mean change (SD; CI)              p-value
  ------------------------- ------------ ------------- ------------- --------------------------------- ---------
  HAQ score, mean (SD)      1.3 (0.60)   0.71 (0.66)   0.87 (0.72)   --0.44 (0.61; --0.78 to --0.11)   0.02
  SF-36 scores, mean (SD)                                                                              
   PF                       28 (22)      58 (25)       54 (27)       25 (28; 9.8--41)                  0.008
   RP                       15 (31)      50 (41)       35 (45)       20 (39; --1.7 to 42)              0.07
   BP                       25 (26)      66 (29)       60 (34)       35 (35; 16--55)                   0.006
   GH                       59 (22)      68 (25)       57 (21)       --2.1 (16; --11 to 6.9)           0.6
   VT                       33 (25)      62 (24)       54 (25)       20 (26; 4.5--35)                  0.03
   SF                       60 (31)      80 (29)       76 (27)       16 (29; 0.034--32)                0.04
   RE                       60 (44)      79 (35)       84 (35)       24 (39; 3.0--46)                  0.04
   MH                       79 (21)      87 (19)       86 (18)       7.2 (17; --2.4 to 17)             0.2

When we imputed baseline data at 12 months, the significant p-values originally obtained (for PF, RP, BP, SF, RE, and HAQ) were still significant.

Discussion {#ss8}
==========

Lower limb function has been shown to deteriorate more than upper limb function over a 10-year period in RA patients ([@CIT0023]). However, few studies have assessed patient-relevant outcome after surgery to the lower extremities. [@CIT0022] compared surgery in the upper and lower extremities and replacement surgery with non-replacement surgery in 255 patients with inflammatory arthropathies (two-thirds of whom had RA). As might be expected, the largest improvement at 12 months---as measured by the standard response mean (SRM)---was for pain reported from the specific joint that had been operated on. SF-36 subscales PF and BP also showed high SRMs, while SRMs for GH and HAQ were lower. In a study by [@CIT0018] assessing costs and outcomes of total joint replacement surgery for 42 Australian RA patients (31 patients undergoing total knee arthroplasty (TKA) and 11 patients undergoing total hip arthroplasty (THA)), the subjects were followed for 12 months postoperatively. The results were similar to ours, with statistically significant improvements in PF and BP for both knee and hip patients, while neither group improved regarding GH. Hip patients also showed better results in subscales related to other aspects of psychology (VT and MH). Similar results have been found for osteoarthritis patients ([@CIT0001]) and in RA drug trials ([@CIT0019], [@CIT0031]), where aspects of patient psychology were less affected by pharmacological treatment. It has been proposed that the effect of successful RA treatment may first affect relief of pain, mobility, physical function, and physical role activities---and emotional well-being only later ([@CIT0016]). In a follow-up study of osteoarthritis patients undergoing THA (n = 108) and TKA (n = 86) ([@CIT0001]), the SF-36 at 12 months was less responsive than the WOMAC, which is a disease-specific questionnaire for patients with osteoarthritis of the lower limb ([@CIT0002]). The relative improvement was most pronounced for physical functioning and physical role functioning. Similarly to our data, the GH subscale after TKA remained unaltered.According to the authors this might be explained by the fact that---even after a successful operation---pain and restrictions in daily life remain, making patients rate their general health as insufficient. Moreover, the chronic course of RA can make evaluation of a specific surgical procedure and its effect on the patient more challenging to interpret ([@CIT0020]), which should be kept in mind when comparing RA surgery and surgery for osteoarthritis. In joint replacement studies including both osteoarthritis patients and RA patients ([@CIT0009], [@CIT0004]), RA patients were more satisfied than osteoarthritis patients after surgery. It was suggested that the moderate correlation between satisfaction and postoperative function could be partly explained by the different expectations of the patients preoperatively ([@CIT0004]). As for osteoarthritis patients undergoing knee arthroplasty, outcome of pain and function is best after 12 months ([@CIT0021]) but major improvement is evident as early as 6 months postoperatively for RA patients. Improvement in pain has high priority in RA patients ([@CIT0012]) and pain remains the most important indication for RA surgery. In our analysis, for every patient group there was a statistically significant improvement in the SF-36 subscale BP postoperatively compared to preoperatively.

One important limitation of our analysis was the large loss to follow-up. This was a retrospective study based on questionnaire data from a register. The majority of patients only had one hospital admission. Follow-up questionnaires were sent by mail at 6 and 12 months without reminders. No statistically significant differences were found in age, preoperative SF-36 scores, or HAQ score between responders and non-responders. The results were sensitive for imputation of baseline data at 12 months for non-responders. Since data were collected from a register, we could not influence the number of follow-up occasions. Repeated evaluations would have been interesting, as the greatest improvement was seen in the first 6 months. We lacked baseline data for a large number of patients, especially early in the inclusion period. One explanation could be an absence of routines for supplying the patients with questionnaires from the start. Hopefully RAKIR will provide opportunities for further follow-up studies in the future.

In conclusion, our data suggest that orthopedic RA-related surgery of the lower extremities has a strong effect on pain and physical function. Improvement is seen as early as 6 months postoperatively and is still apparent after 12 months.

AN coordinated the data collection. AN and AB designed the study, participated in interpretation of the data, and critically revised the manuscript. ACB analyzed the data and drafted the manuscript. All the authors read and approved the final manuscript.

We thank Professor Ulf Strömberg for statistical advice.

No competing interests declared.
